Abstract: An object of the present invention is to provide an anti-tumor agent that exhibits a remarkably excellent anti-tumor effect. According to the present invention, there is provided an anti-tumor agent for curing cancer, the anti-tumor agent having a liposome which has an inner water phase and having an aqueous solution which is an outer water phase and disperses the liposome, in which the liposome encompasses topotecan or a salt thereof, a lipid constituting the liposome contains a lipid modified with polyethylene glycol, dihydrosphingomyelin, and cholesterol, the inner water phase contains an ammonium salt, and the topotecan or the salt thereof encompassed in the liposome is administered at a dose rate of 0.1 mg/m2 body surface area to 10 mg/m2 body surface area, in terms of topotecan per administration.

Abstract: An object of the present invention is to provide a treatment agent for Merkel cell cancer. According to the present invention, there is provided a treatment agent for Merkel cell cancer, having a liposome which has an inner water phase and having an aqueous solution which is an outer water phase and disperses the liposome, in which the liposome encompasses topotecan or a salt thereof, a lipid constituting the liposome contains a lipid modified with polyethylene glycol, dihydrosphingomyelin, and cholesterol, and the inner water phase contains an ammonium salt.

Abstract: An object of the present invention is to provide a pharmaceutical formulation obtained by combining a liposome composition, in which liposomes encapsulate a drug, with a platinum preparation. According to the present invention, there is provided a pharmaceutical formulation including (A) a liposome composition in combination with (B) a platinum preparation, in which the liposome composition includes, as constitutional components of a liposome membrane, a hydrophilic polymer-modified diacylphosphatidylethanolamine; a dihydrosphingomyelin; and cholesterols, the liposome composition includes a drug and has an inner water phase containing ammonium sulfate, a molar ratio of sulfate ions in the inner water phase to the drug in an entire water phase is 0.36 or more, and the liposome composition and the platinum preparation are administered simultaneously or sequentially.

Abstract: An object of the present invention is to provide a pharmaceutical formulation obtained by combining a liposome composition in which liposomes encapsulate a drug with an immune checkpoint inhibitor. According to the present invention, there is provided a pharmaceutical formulation including (A) a liposome composition in combination with (B) an immune checkpoint inhibitor, in which the liposome composition includes, as constitutional components of a liposome membrane, a hydrophilic polymer-modified diacylphosphatidylethanolamine; a dihydrosphingomyelin, and cholesterols, the liposome composition includes a drug and has art inner water phase containing ammonium sulfate, a molar ratio of sulfate ions in the inner water phase to the drug in an entire water phase is 0.36 or more, and the liposome composition and the immune checkpoint inhibitor are administered simultaneously or sequentially.

Abstract: A process for the production of a black coloring material characterised by treating a compound selected from finely powdered sugar, protein and a polyamide polymer, having amino groups with a naphthoquinone derivative represented by the general formula (1): ##STR1## wherein R.sub.1 represents a hydrogen atom, a hydroxyl group, a halogen atom, or a group represented by the following formula: ##STR2## wherein R.sub.2 represents a hydrogen atom or a hydroxyl group, R.sub.3 represents an alkyl group, an alkenyl group or a hydroxylalkyl group, and n represents 1 or 2; cosmetics comprising a black coloring material produced by the above process; and a process for staining a substrate using the obtained black coloring material.

Abstract: A pair of side panels of a car stereo have threaded holes. A pair of brackets are secured to the side panels for mounting the car stereo on a frame of an automobile. A preventing sheet is attached to a reverse side of the side panel for preventing chips broken off from the screws and the threaded holes from falling in a space behind the side panel.

Abstract: A novel black coloring material is obtained by treating a chitosan with a dyestuff of the lithospermum root. If a water-insoluble chitosan is used as the chitosan, a finely divided black coloring material is obtained, and if a gelatinous chitosan salt is used as the chitosan, a gelatinous black coloring material is obtained. If a water-soluble chitosan, chitosan oligosaccharide or D-glucosamine, or a salt thereof is used as the chitosan, a liquid black coloring material is obtained. If a powdery polymeric substance is treated with such a black coloring material, a polymer-based black coloring material is obtained, and if a fiber is dyed with such a black coloring material, the fiber is dyed to a black color having a low lightness.

Abstract: Phenylacetic acid is produced by reacting chlorotoluene with sodium to form tolylsodium, rearranging the product to benzyl sodium and then reacting the benzyl sodium with a carboxylating agent.